We have located links that may give you full text access.
Antagonistic activity of a novel antifungalmycin N2 from Streptomyces sp. N2 and its biocontrol efficacy against Rhizoctonia solani.
FEMS Microbiology Letters 2019 January 24
Antifungalmycin N2 (3-methyl-3,5-amino-4-vinyl-2-pyrone, C6H7O2N) is a novel bioactive substance produced by Streptomyces sp. N2. In the present work, the antagonistic activity of antifungalmycin N2 and its biocontrol efficacy on Rhizoctonia solani were carried out to evaluate its potential as a biocontrol agent against fungal plant diseases. By using potato dextrose agar (PDA) media for in vitro cultivation of phytopathogenic fungi, the results showed that antifungalmycin N2 not only displayed broad-spectrum antifungal activities against various plant pathogenic fungi, but also had a strong antagonism to the sclerotial germination of R. solani. In a detached leaf assay, it was found that antifungalmycin N2 could effectively protect the rice leaves form the infection of R. solani, resulting in a significantly reduced sheath blight severity on the surfaces of rice leaves. In the pot experiments, the results also revealed that significantly lower sheath blight infections occurred in the tissues of the treated rice plants, which further confirmed that antifungalmycin N2 had a favorable biocontrol efficacy on rice sheath blight. In conclusion, the above results indicated that the novel antifungalmycin N2 was one of promising biocontrol agents for plant disease control.
Full text links
Related Resources
Trending Papers
Challenges in Septic Shock: From New Hemodynamics to Blood Purification Therapies.Journal of Personalized Medicine 2024 Februrary 4
Molecular Targets of Novel Therapeutics for Diabetic Kidney Disease: A New Era of Nephroprotection.International Journal of Molecular Sciences 2024 April 4
The 'Ten Commandments' for the 2023 European Society of Cardiology guidelines for the management of endocarditis.European Heart Journal 2024 April 18
A Guide to the Use of Vasopressors and Inotropes for Patients in Shock.Journal of Intensive Care Medicine 2024 April 14
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app